Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Brenner
Paul
P
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D003270:Contraceptive Agents / Q000008:administration & dosage*; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D009644:Norgestrel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011247:Pregnancy; D012306:Risk; D013923:Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology*
D003270:Contraceptive Agents; D003277:Contraceptives, Oral, Combined; D009644:Norgestrel; D004997:Ethinyl Estradiol; C017576:norgestimate